by TractManager | May 9, 2016 | Emerging Technology Report
An oral epidermal growth factor receptor inhibitor for the treatment of non-small cell lung cancer in patients with initial activating epidermal growth factor receptor mutations as well as the T790M dominant acquired resistance mutation.If you have a Hayes login,...
by TractManager | May 9, 2016 | Emerging Technology Report
A single-pill grazoprevir/elbasvir regimen for chronic HCV genotype 1, 4, or 6 infection. If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | May 5, 2016 | Molecular Test Assessment
Non-small cell lung cancer (NSCLC) encompasses squamous cell carcinoma, large cell carcinoma, and adenocarcinoma. In the United States in 2015, it is estimated that NSCLC was diagnosed in more than 221,000 individuals and...
by TractManager | May 2, 2016 | Emerging Technology Report
A novel oral 5HT2A inverse agonist for the treatment of psychosis associated with Parkinson disease.If you have a Hayes login, click here to view the full report on the Knowledge Center.
Recent Comments